The drug Kadcyla T-DM1; trastuzumab emtansine may be a better choice than Herceptin trastuzumab in patients with HER2-positive breast cancer who still have disease after their initial drug treatment, according to research presented December 5 at the San Antonio Breast Cancer Symposium in Texas. The results were published simultaneously in the New England Journal of Medicine. The findings are from the KATHERINE clinical trial , which was established to see if treating HER2-positive breast cancer patients at higher risk for cancer recurrence following neoadjuvant therapy that takes place prior to surgery with Kadcyla instead of the standard therapy, Herceptin , lowered the risk of recurrence. Kadcyla is composed of trastuzumab and the chemotherapy agent DM1. The study is important because patients who are found to have residual cancer at the time of surgery, following neoadjuvant therapy, have a worse prognosis and need more effective therapies, says Charles E.
Recent Advances in Breast Cancer Research & Treatment
Breast Cancer Treatment | Treatment Options for Breast Cancer
Let friends in your social network know what you are reading about. The largest breast cancer treatment trial ever conducted will help doctors provide more personalized treatment for patients. A link has been sent to your friend's email address. A link has been posted to your Facebook feed. Please read the rules before joining the discussion. Chemotherapy is no longer considered to be a beneficial treatment method for certain types of women with early stage of breast cancer, according to the TAILORx trial, the largest breast cancer treatment trial ever conducted.
Recent breast cancer trial changes how doctors build personalized treatment plans
Breast cancer is treated in several ways. It depends on the kind of breast cancer and how far it has spread. People with breast cancer often get more than one kind of treatment.
The report covers scope and product overview in order to discover the key terms and offer in-depth information on market dynamics. Biggest Opportunity In Global Breast Cancer Treatment Market Report offers significant insights into the overall research will touch a new level in the upcoming year along with the market dimensions and evaluation for the duration to The exhaustive research study covers extensive analysis of various industry segments based on application analysis by , Technology and Product Type, and different geographical regions and CAGR status forecast to Further, breast cancer treatment market report along with computable information, qualitative information sets and evaluation tools are provided in this study for improved analysis of the overall market scenario and prospects. The information such as industry predilection insights and drivers, challenges and fortuity assists the readers for understanding the current trends.